Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 83551-83600 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05576961
Safety and Efficacy of RX-af01 Combined With PD-1 Antibody
PHASE1/PHASE2Recruiting
60 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT06954961
A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer
PHASE3Recruiting
640 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor2 locations
NCT05519449
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
PHASE1Recruiting
272 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2028
3 conditions1 sponsor26 locations
NCT05444361
Ultrasound-Guided Percutaneous Cryoneurolysis to Treat Postoperative Pain After Mastectomy
NAEnrolling by invitation
216 participants
Started: Sep 15, 2022 · Completed: May 14, 2028
1 condition2 sponsors5 locations
NCT05450692
A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy
PHASE3Active, not recruiting
594 participants
Started: Sep 15, 2022 · Completed: Oct 6, 2025
1 condition2 sponsors193 locations
NCT05325034
Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
NARecruiting
2,000 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2026
4 conditions2 sponsors22 locations
NCT05415137
Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
PHASE3Active, not recruiting
268 participants
Started: Sep 15, 2022 · Completed: Aug 31, 2025
1 condition2 sponsors91 locations
NCT04862637
Detecting the Changes of Swallowing Function in Oral Cancer Patients
N/ARecruiting
40 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05067491
Bringing Exposure Therapy to Real-Life Context With Augmented Reality-Dogs (ARET)-Dogs
NAActive, not recruiting
25 participants
Started: Sep 15, 2022 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05272254
Povidone Iodine Efficacy Study
PHASE2Recruiting
246 participants
Started: Sep 15, 2022 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT04789616
The Canadian Maraviroc Randomized Controlled Trial To Augment Rehabilitation Outcomes After Stroke
PHASE2Recruiting
120 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2025
1 condition10 sponsors6 locations
NCT05307263
Combination Therapy of Atherectomy Plus Drug-coated Balloon Versus Drug-coated Balloon for Complex Femoropopliteal Artery Disease
NARecruiting
300 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT06378216
Myotonic Dystrophy Type 1 Congenital and Juvenile Form: From Diagnosis to Rehabilitation [MDCJ-NeuBeRe]
N/ARecruiting
30 participants
Started: Sep 15, 2022 · Completed: Dec 30, 2024
1 condition1 sponsor1 location
NCT05620121
ACute Treatment of Incisional Ventral Hernia
N/ARecruiting
500 participants
Started: Sep 15, 2022 · Completed: Apr 30, 2024
1 condition1 sponsor1 location
NCT06426420
Endometriosis and ATR-FTIR Spectroscopy
NARecruiting
600 participants
Started: Sep 15, 2022 · Completed: Apr 29, 2026
2 conditions2 sponsors1 location
NCT06211582
Clinical Performances of 3-different Tooth-colored Restorative Materials in Class-II Cavities
NAActive, not recruiting
47 participants
Started: Sep 15, 2022 · Completed: Mar 20, 2024
1 condition1 sponsor1 location
NCT05522504
Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout
N/AActive, not recruiting
600 participants
Started: Sep 15, 2022 · Completed: Feb 28, 2025
4 conditions1 sponsor1 location
NCT05482568
A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer
PHASE1/PHASE2Recruiting
324 participants
Started: Sep 15, 2022 · Completed: Dec 30, 2024
1 condition1 sponsor2 locations
NCT05502380
Broad-spectrum Antibiotic Prophylaxis in Tumor and Infected Orthopedic Surgery
PHASE3Recruiting
1,100 participants
Started: Sep 15, 2022 · Completed: Dec 12, 2025
3 conditions1 sponsor1 location
NCT05520281
Short-term Psychodynamic Psychotherapy in Serious Physical Illness
NAActive, not recruiting
50 participants
Started: Sep 15, 2022 · Completed: Jul 31, 2025
3 conditions1 sponsor4 locations
NCT05757206
The Syn-Sleep Study
N/AActive, not recruiting
80 participants
Started: Sep 15, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor8 locations
NCT05329285
CABG or PCI in Patients With Ischemic Cardiomyopathy
NARecruiting
470 participants
Started: Sep 14, 2022 · Completed: Dec 31, 2052
1 condition4 sponsors1 location
NCT06398366
Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence
N/AEnrolling by invitation
2,000 participants
Started: Sep 14, 2022 · Completed: Dec 31, 2026
1 condition26 sponsors1 location
NCT05729399
Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors
PHASE1/PHASE2Recruiting
42 participants
Started: Sep 14, 2022 · Completed: May 1, 2025
1 condition1 sponsor4 locations
NCT05609253
Itraconazole to Prevent Recurrent Barrett's Esophagus
PHASE1Active, not recruiting
10 participants
Started: Sep 14, 2022 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05433636
Mindful Waiting Room
NARecruiting
305 participants
Started: Sep 14, 2022 · Completed: Dec 1, 2024
6 conditions1 sponsor1 location
NCT05300893
Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture
NARecruiting
154 participants
Started: Sep 14, 2022 · Completed: Jan 31, 2027
2 conditions1 sponsor3 locations
NCT05384821
Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906)
PHASE1/PHASE2Recruiting
28 participants
Started: Sep 14, 2022 · Completed: Oct 31, 2028
1 condition1 sponsor18 locations
NCT05562323
Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study
N/ARecruiting
100 participants
Started: Sep 14, 2022 · Completed: Aug 31, 2026
1 condition3 sponsors3 locations
NCT05541406
Efficacy of a Multi-level School Intervention for LGBTQ Youth
NARecruiting
450 participants
Started: Sep 14, 2022 · Completed: Dec 1, 2025
9 conditions3 sponsors21 locations
NCT05344612
Comparing a Diagnostic and Treatment Strategy of Upfront CTCA With SOC in Patients With Chest Pain and Suspected CAD
NARecruiting
6,444 participants
Started: Sep 14, 2022 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT05170399
Vaccine Responses in Patients With B Cell Malignancies
PHASE4Recruiting
500 participants
Started: Sep 14, 2022 · Completed: Aug 16, 2026
1 condition1 sponsor1 location
NCT05360290
CTCs in Breast Cancer After Neoadjuvant Treatment and Surgery: a Multicenter, Prospective Clinical Trial
NARecruiting
484 participants
Started: Sep 14, 2022 · Completed: Jun 30, 2029
2 conditions1 sponsor1 location
NCT05288361
The DISCOVER INOCA Prospective Multi-center Registry
N/ARecruiting
500 participants
Started: Sep 14, 2022 · Completed: Dec 31, 2032
6 conditions2 sponsors9 locations
NCT05147909
Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity
NARecruiting
124 participants
Started: Sep 14, 2022 · Completed: Mar 30, 2028
3 conditions1 sponsor1 location
NCT05547529
The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer
PHASE3Recruiting
156 participants
Started: Sep 14, 2022 · Completed: Sep 14, 2027
1 condition1 sponsor1 location
NCT05465941
PLX038 for Treatment of Metastatic Platinum-resistant Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
PHASE2Recruiting
43 participants
Started: Sep 14, 2022 · Completed: Dec 31, 2031
6 conditions2 sponsors1 location
NCT05625971
Non-invasive MRD Assessment in Multiple Myeloma
N/ARecruiting
88 participants
Started: Sep 14, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT06547515
Bone and Muscle Health Following Sleeve Gastrectomy in Men, Premenopausal and Postmenopausal Women
N/ARecruiting
156 participants
Started: Sep 14, 2022 · Completed: Aug 15, 2026
4 conditions2 sponsors1 location
NCT06082687
De-identified Human Tissue Project
N/ARecruiting
1,000,000 participants
Started: Sep 14, 2022 · Completed: Sep 30, 2027
1 condition1 sponsor1 location
NCT04619225
Cardiac Output and Recovery Time
NAEnrolling by invitation
50 participants
Started: Sep 14, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05172765
Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
NARecruiting
160 participants
Started: Sep 14, 2022 · Completed: May 29, 2026
1 condition1 sponsor1 location
NCT05519384
Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid Leukemia
EARLY_PHASE1Recruiting
12 participants
Started: Sep 14, 2022 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT05037656
Testing a School-Based E-cigarette, Tobacco, and Betel (Areca) Nut Use Prevention Curriculum for Guam Youths
NAActive, not recruiting
538 participants
Started: Sep 14, 2022 · Completed: Aug 31, 2025
3 conditions3 sponsors1 location
NCT05761067
STICH-3.0 International Trial Consortium
NARecruiting
2,800 participants
Started: Sep 14, 2022 · Completed: Sep 14, 2029
2 conditions14 sponsors1 location
NCT05557058
GORE Glaucoma Drainage Implant Clinical Study Dominican Republic
NAActive, not recruiting
20 participants
Started: Sep 14, 2022 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05423379
XIENCE Skypoint Large Vessel Post Approval Study
N/AActive, not recruiting
102 participants
Started: Sep 14, 2022 · Completed: Aug 30, 2027
1 condition1 sponsor18 locations
NCT05621486
A Clinical Study to Evaluate B4T2-001 CAR T Cells in the Treatment of Advanced Solid Tumors
PHASE1Active, not recruiting
36 participants
Started: Sep 14, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors2 locations
NCT05489887
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
PHASE2Recruiting
93 participants
Started: Sep 14, 2022 · Completed: Sep 30, 2036
1 condition2 sponsors23 locations
NCT06265597
The Effect of Healthy Nutrition and Yoga Program on Obese Children
NAEnrolling by invitation
33 participants
Started: Sep 14, 2022 · Completed: Jun 1, 2025
1 condition1 sponsor1 location